Trial Profile
Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes [Efficacia e meccanismi di un trattamento insulinico intensivo di breve durata sulla remissione o risposta alla terapia orale del diabete di tipo 2]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Eli Lilly and Company
- 10 Mar 2022 Status changed from recruiting to completed.
- 27 Feb 2014 New trial record